Total Payments
$12,140
2024 Payments
$1,260
Companies
50
Transactions
512
Medicare Patients
5,426
Medicare Billing
$497,928
Payment Breakdown by Category
Food & Beverage$12,045 (99.2%)
Education$95.34 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,045 | 506 | 99.2% |
| Education | $95.34 | 6 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,964 | 106 | $0 (2024) |
| Novo Nordisk Inc | $1,209 | 65 | $0 (2024) |
| Lilly USA, LLC | $1,168 | 60 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $781.95 | 35 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $619.59 | 17 | $0 (2022) |
| Abbott Laboratories | $595.72 | 10 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $474.43 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $334.54 | 12 | $0 (2024) |
| PFIZER INC. | $323.85 | 16 | $0 (2024) |
| Amgen Inc. | $297.82 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,260 | 46 | AstraZeneca Pharmaceuticals LP ($463.16) |
| 2023 | $621.91 | 25 | Lilly USA, LLC ($117.72) |
| 2022 | $1,314 | 56 | AstraZeneca Pharmaceuticals LP ($392.79) |
| 2021 | $1,939 | 92 | AstraZeneca Pharmaceuticals LP ($532.22) |
| 2020 | $1,263 | 57 | AstraZeneca Pharmaceuticals LP ($434.49) |
| 2019 | $1,021 | 47 | AstraZeneca Pharmaceuticals LP ($411.09) |
| 2018 | $1,069 | 55 | AstraZeneca Pharmaceuticals LP ($231.86) |
| 2017 | $3,653 | 134 | SANOFI-AVENTIS U.S. LLC ($521.88) |
All Payment Transactions
512 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $129.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Hyperkalemia | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Cardio-renal | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Bone Health | ||||||
| 07/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Obesity | ||||||
| 06/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Respiratory | ||||||
| 06/21/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $18.08 | General |
| 05/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,258 | 1,578 | $245,850 | $113,676 |
| 2022 | 8 | 1,306 | 1,765 | $283,540 | $128,182 |
| 2021 | 10 | 1,409 | 1,979 | $327,675 | $147,456 |
| 2020 | 10 | 1,453 | 1,941 | $309,345 | $108,613 |
Total Patients
5,426
Total Services
7,263
Medicare Billing
$497,928
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 321 | 627 | $125,400 | $60,997 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 263 | 263 | $73,700 | $38,082 | 51.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,800 | $2,826 | 58.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 236 | 237 | $11,470 | $2,587 | 22.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $5,050 | $2,582 | 51.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,000 | $1,798 | 59.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 33 | $6,600 | $1,463 | 22.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 257 | 257 | $6,255 | $1,094 | 17.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $2,500 | $865.75 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,750 | $860.16 | 49.2% |
| G0405 | Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination | Office | 2023 | 49 | 49 | $4,860 | $260.48 | 5.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 31 | $465.00 | $260.40 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 349 | 771 | $154,200 | $77,187 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 266 | 266 | $79,800 | $39,879 | 50.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 288 | 298 | $20,720 | $3,321 | 16.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 38 | 52 | $10,400 | $2,504 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 42 | $5,250 | $2,251 | 42.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 55 | $5,430 | $1,901 | 35.0% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 235 | 235 | $7,050 | $1,003 | 14.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 39 | 46 | $690.00 | $136.32 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 381 | 915 | $183,100 | $91,417 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 266 | 266 | $79,800 | $40,765 | 51.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 291 | 301 | $30,100 | $3,362 | 11.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 16 | 16 | $4,300 | $3,007 | 69.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 12 | 12 | $4,800 | $2,316 | 48.2% |
About Dr. Doris Pablo-Bustos, M.D
Dr. Doris Pablo-Bustos, M.D is a Primary Care healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275635559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Doris Pablo-Bustos, M.D has received a total of $12,140 in payments from pharmaceutical and medical device companies, with $1,260 received in 2024. These payments were reported across 512 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($12,045).
As a Medicare-enrolled provider, Pablo-Bustos has provided services to 5,426 Medicare beneficiaries, totaling 7,263 services with total Medicare billing of $497,928. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Primary Care, Exclusive Provider Organization
- Location Washington, DC
- Active Since 09/05/2006
- Last Updated 10/11/2024
- Taxonomy Code 261QP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275635559
Products in Payments
- FARXIGA (Drug) $1,414
- TRULICITY (Drug) $710.15
- JANUVIA (Drug) $542.62
- CardioMEMS HF System (Device) $537.22
- Ozempic (Drug) $533.74
- JARDIANCE (Drug) $531.48
- TOUJEO (Drug) $486.67
- BREZTRI (Drug) $437.59
- LOKELMA (Drug) $335.54
- Veltassa (Drug) $284.46
- ACTHAR (Biological) $275.64
- ENTRESTO (Drug) $258.21
- Victoza (Drug) $241.72
- Velphoro (Drug) $221.71
- SYMBICORT (Drug) $217.46
- Kerendia (Drug) $209.54
- BEVESPI AEROSPHERE (Drug) $185.01
- Vascepa (Drug) $183.24
- Auryxia (Drug) $178.60
- ELIQUIS (Drug) $155.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Washington
Jessicamarie Fox-Bartlett, Np-C, NP-C
Primary Care — Payments: $5,140
Primary Care $5,140
Mr. Tyson Anderson, Mph, Msn, Agnp-C, MPH, MSN, AGNP-C
Primary Care — Payments: $3,634
Primary Care $3,634
Taylor Popp, Np, NP
Primary Care — Payments: $2,074
Primary Care $2,074
Mrs. Michaela Brady, Crnp, CRNP
Primary Care — Payments: $1,210
Primary Care $1,210
Getachew Afre, Md, MD
Primary Care — Payments: $1,081
Primary Care $1,081
Rita Chioma, Aprn, APRN
Primary Care — Payments: $875.04
Primary Care $875.04